Latest tech news for May.
Gene therapy
Oxford Genetics has received £6.5m of new investment in a syndicated round. This means it now has an undiluted, post-money valuation of £30.5m.
In the last 12 months, it has won six new licensing deals for its scalable gene therapy manufacturing.
Ryan Cawood, Founder and Chief Executive, said: “Our customer base is shaping up to be an impressive collection of long-term partners and in addition, our increasing global reach is enabling us to further demonstrate our technical excellence and clear market differentiation.”
The company offers a suite of solutions for gene therapy drug discovery, antibody therapy development and CRISPR gene editing.
MicroSlide
Ortho Clinical Diagnostics has received a CE Mark for its new technology for clinical labs, the VITROS XT MicroSlide.
The MicroSlide will offer clinical labs the ability to simultaneously perform two tests per slide from a single blood sample, for the first time. Tests often ordered together, such as cholesterol and triglycerides, can now be performed simultaneously.
It is claimed this will improve performance, save time and lab space.
Reagent kit
HORIBA Medical has announced the launch of a D-dimer parameter for its Yumizen G haemostasis range of instruments.
The Yumizen G DDi 2 reagent kit offers a key measurement and reference exclusion test for the diagnosis of deep vein thrombosis and pulmonary embolism. It can also be used for monitoring the progress and effectiveness of treatment of disseminated intravascular coagulation.
The kit is available for its full range of coagulation instruments which covers the needs of any lab.